Clinical Trial Update: The Utility of feNO in the Differential Diagnosis of Chronic Cough [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the utility of fractional exhaled nitric oxide (feNO) in differentiating chronic cough etiologies, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Cough | Phase 4 | Status: COMPLETED